Responses
Clinical and epidemiological research
Extended report
Phase III, multicentre, double-blind, randomised, parallel-group study to evaluate the similarities between LBEC0101 and etanercept reference product in terms of efficacy and safety in patients with active rheumatoid arthritis inadequately responding to methotrexate
Compose a Response to This Article
Other responses
No responses have been published for this article.